Incidence of microvascular dysfunction is increased in hyperlipidemic mice, reducing cerebral blood flow and impairing remote memory

Front Endocrinol (Lausanne). 2024 Feb 26:15:1338458. doi: 10.3389/fendo.2024.1338458. eCollection 2024.

Abstract

Introduction: The development of cognitive dysfunction is not necessarily associated with diet-induced obesity. We hypothesized that cognitive dysfunction might require additional vascular damage, for example, in atherosclerotic mice.

Methods: We induced atherosclerosis in male C57BL/6N mice by injecting AAV-PCSK9DY (2x1011 VG) and feeding them a cholesterol-rich Western diet. After 3 months, mice were examined for cognition using Barnes maze procedure and for cerebral blood flow. Cerebral vascular morphology was examined by immunehistology.

Results: In AAV-PCSK9DY-treated mice, plaque burden, plasma cholesterol, and triglycerides are elevated. RNAseq analyses followed by KEGG annotation show increased expression of genes linked to inflammatory processes in the aortas of these mice. In AAV-PCSK9DY-treated mice learning was delayed and long-term memory impaired. Blood flow was reduced in the cingulate cortex (-17%), caudate putamen (-15%), and hippocampus (-10%). Immunohistological studies also show an increased incidence of string vessels and pericytes (CD31/Col IV staining) in the hippocampus accompanied by patchy blood-brain barrier leaks (IgG staining) and increased macrophage infiltrations (CD68 staining).

Discussion: We conclude that the hyperlipidemic PCSK9DY mouse model can serve as an appropriate approach to induce microvascular dysfunction that leads to reduced blood flow in the hippocampus, which could explain the cognitive dysfunction in these mice.

Keywords: atherosclerosis AAV-PCSK9DY mouse model; cerebral blood flow; cognitive dysfunction; hyperlipidemia; patchy blood-brain barrier leaks; pericytes.

MeSH terms

  • Animals
  • Atherosclerosis* / metabolism
  • Cerebrovascular Circulation / physiology
  • Cholesterol
  • Hyperlipidemias* / pathology
  • Incidence
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Proprotein Convertase 9 / genetics

Substances

  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Cholesterol

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by research grants from the German Research Foundation to the GRK 1957 “Adipocyte-Brain Crosstalk”, University of Lübeck and GRK 2154 “Materials for Brain”, University of Kiel, and a grant from the German Centre for Cardiovascular Research (DZHK) through a shared expertise SE097 – registration number 81X2700138 – Universities of Lübeck and Frankfurt.